There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize...
Students Experiencing an Emotional Crisis Can Receive Immediate Support from Crisis Support Team via Text, Chat, or Phone–Anytime, Anywhere Gaggle’s new ReachOut student...
Riverbed, the leader in Unified Observability, announced that Fujitsu, a market leading global IT service provider, selected Alluvio Aternity, as...
CloudMD Software & Services (TSXV: DOC) continues to shed assets as it looks to achieve profitability. The company has sold The post CloudMD Sells...
The S&P/ASX 200 closed 0.42% to the good, on the back of the RBA interest rate-hiking pause. ... Read More The post CLOSING BELL: ASX closes...
The ASX is struggling ahead of today's RBA rate call, while two Small Caps health care mobs deliver great gains ... Read More The post ASX...
S&P/ASX 200 closes +0.62%, in decent form for the first business day of the financial year, with IT down but ... Read More The post CLOSING...
We explore the case for psychedelic decriminalization and how drug policies impact public health. The post Psychedelic Decriminalization: How Drug Policies...
Cybin has reported audited financial results for fiscal year 2023 and recent business highlights. The post Cybin Reports 2023 Financial Results and Business...
Local initiatives and cultural changes are playing a pivotal role in spearheading decriminalization and legalization efforts and the future of legal psychedelics. The...
PharmaTher Initiates Filing of Abbreviated New Drug Application for KETARX™ (racemic ketamine) to the FDA The post PharmaTher Initiates Filing of Abbreviated...
With clinical trials moving MDMA toward FDA approval, celebrities continuing to share their psychedelic experiences, and politicians supporting new research...
Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights The post Small Pharma Reports 2023 Financial...
Spravato provides insights into market potential of legal psychedelics - we take a closer look. The post The Commercial Market for Legal Psychedelics:...
This is the FDA’s first guidance focusing on psychedelic drug development. Phillips Lytle law firm takes a closer look. The post FDA Draft Guidance on...
On 6th July, PSYCH Symposium returns to London to explore emerging research, technologies and opportunities which have the potential to reshape the landscape...